Pharmaceutical Products for CDER Research Studies - IDIQ

Inactive
Notice ID:75F40126Q132721

This opportunity is for a follow-on contract to provide services previously performed by WE Pharma, LLC. The prior contract had a total ceiling value of $9,500,000.00 and a period of performance from September 30, 2020, to September 29, 2025. No specific budget amount for the new contract is provided in the description. The location for performance of services is not specified. Prospective bidders should review the attached combined synopsis/solicitation and amendment for full details.

Department/Ind.Agency Subtier Office
HEALTH AND HUMAN SERVICES, DEPARTMENT OF FOOD AND DRUG ADMINISTRATION FDA OFFICE OF ACQ GRANT SVCS
  PSC   DRUGS AND BIOLOGICALS


Data sourced from SAM.gov. View Official Posting »

Pharmaceutical Products for CDER Research Studies - IDIQ

Notice ID:75F40126Q132721

5/4/2026: See attached amendment 1 which updates the SBCX link for the subcontracting plan. See attached combined synopsis/solicitation.

Department/Ind.Agency Subtier Office
HEALTH AND HUMAN SERVICES, DEPARTMENT OF FOOD AND DRUG ADMINISTRATION FDA OFFICE OF ACQ GRANT SVCS
  PSC   6505 DRUGS AND BIOLOGICALS


Data sourced from SAM.gov. View Official Posting »

Pharmaceutical Products for CDER Research Studies - IDIQ

Notice ID:75F40126Q132721

See attached combined synopsis/solicitation.

Department/Ind.Agency Subtier Office
HEALTH AND HUMAN SERVICES, DEPARTMENT OF FOOD AND DRUG ADMINISTRATION FDA OFFICE OF ACQ GRANT SVCS
  PSC   6505 DRUGS AND BIOLOGICALS
LOCATION: Not Given
Primary Contact
Nick Sartain
301-***-1988


Data sourced from SAM.gov. View Official Posting »